These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1296850)

  • 1. [Ultrastructure of the myocardium in the calcium channel blocker withdrawal syndrome].
    Devecka V; Kovácsová B; Svec P
    Bratisl Lek Listy; 1992 Dec; 93(12):605-9. PubMed ID: 1296850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the calcium channel antagonist, verapamil and ethanol on the myocardial ultrastructure in the rat.
    Dul B; Gajkowska B
    Exp Toxicol Pathol; 1997 Dec; 49(6):493-6. PubMed ID: 9495652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of ethanol and the calcium channel antagonist, nifedipine on myocardial ultrastructure in the rat.
    Dul B; Gajkowska B
    Exp Toxicol Pathol; 1998 Mar; 50(1):27-30. PubMed ID: 9570498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in myocardial sensitivity after sudden with withdrawal of calcium channel blockers].
    Tumová I; Racanská E; Svec P
    Bratisl Lek Listy; 1992 Sep; 93(9):453-8. PubMed ID: 1288827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical, structural and ultrastructural changes in the Prague hereditary hypercholesterolemic (PHHC) rats heart after the long treatment with calcium channel blockers.
    Edelsteinova S; Svec P; Augustiniová B; Devecka V; Pazin-Hrickova E
    Pharmazie; 1993 Oct; 48(10):769-72. PubMed ID: 8265711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of calcium channel blockers on withdrawal syndrome of lorazepam in rats.
    Gupta MB; Nath C; Patnaik GK; Saxena RC
    Indian J Med Res; 1996 Jun; 103():310-4. PubMed ID: 8707372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of calcium channel blocker nifedipine on anxiety and seizure manifestations of abstinence syndrome in rats after withdrawal of long-term diazepam administration].
    Garibova TL; Val'dman EA; Voronina TA; Kraĭneva VA
    Biull Eksp Biol Med; 1998 May; 125(5):538-40. PubMed ID: 9644553
    [No Abstract]   [Full Text] [Related]  

  • 9. Rebound vasospasm after coronary revascularization in association with calcium antagonist withdrawal.
    Engelman RM; Hadji-Rousou I; Breyer RH; Whittredge P; Harbison W; Chircop RV
    Ann Thorac Surg; 1984 Jun; 37(6):469-72. PubMed ID: 6732337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute calcium channel blocker withdrawal-induced cardiac arrest.
    Peeters LEJ; den Uil CA; Feyz L; van den Bemt PMLA; Daemen J; Versmissen J
    Neth J Med; 2019 Dec; 77(9):341-343. PubMed ID: 31814590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of ultrastructural changes in the myocardium of rats during withdrawal syndrome after gradual decreasing of metipranolol doses.
    Lazarová Z
    Cor Vasa; 1992; 34(3):283-92. PubMed ID: 1363978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-type calcium channel blockade attenuates morphine withdrawal: in vivo interaction between L-type calcium channels and corticosterone.
    Esmaeili-Mahani S; Fathi Y; Motamedi F; Hosseinpanah F; Ahmadiani A
    Horm Behav; 2008 Feb; 53(2):351-7. PubMed ID: 18177874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blocker withdrawal in a pregnant woman.
    O'Donnell ; Mertl SY; Kelly WN
    Am J Ther; 1999 Jan; 6(1):61-6. PubMed ID: 10610244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rats.
    Colombo G; Agabio R; Lobina C; Reali R; Melis F; Fadda F; Gessa GL
    Alcohol Alcohol; 1995 Jan; 30(1):125-31. PubMed ID: 7748269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect od calcium channel blocker, verapamil on DNA synthesis and activity of nucleolar organizer in myocardial cells of newborn rats].
    Mel'nikova NP; Timoshin SS
    Biull Eksp Biol Med; 1999 Jun; 127(6):658-60. PubMed ID: 10445134
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.